Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT)

CUSIP: 63909J108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
130,367,883
Total 13F shares
33,010,619
Share change
+33,010,619
Total reported value
$331,901,744
Put/Call ratio
89%
Price per share
$10.10
Number of holders
55
Value change
+$331,901,478
Number of buys
55

Quarterly Holders Quick Answers

What is CUSIP 63909J108?
CUSIP 63909J108 identifies NAUT - Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NAUT - Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
AH Equity Partners Bio II, L.L.C.
3/4/5
10%+ Owner —
class O/S missing
17,653,917
 $35,833,921 — 09 Jun 2021
3/4/5

Institutional Holders of Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT) as of Q2 2021

As of 30 Jun 2021, Nautilus Biotechnology, Inc. - Common stock, par value $0.0001 per share (NAUT) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,010,619 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Comprehensive Financial Management LLC, Bain Capital Life Sciences Investors, LLC, ORBIMED ADVISORS LLC, Ally Bridge Group (NY) LLC, Amazon com Inc, Alyeska Investment Group, L.P., Nantahala Capital Management, LLC, and Avidity Partners Management LP. This page lists 55 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q4 2025 Across Filers

Q4 2025 holders
66
Q2 2021 holders
55
Holder diff
-11
Investor Q4 2025 Shares Q2 2021 Shares Share Diff Share Chg % Q4 2025 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .